title: MicroRNA in Melanoma.
abstract: Melanoma is a highly aggressive and deadly skin cancer. Early intervention correlates with nearly 100% patient survival, but greater than 80% mortality is associated with advanced disease. Currently, few treatment options are available for patients with metastatic melanoma, and the global incidence of melanoma is increasing faster than that of other cancers. Therefore, it is vitally important to uncover and use genetic and epigenetic regulatory mechanisms at work during the development and progression of melanoma for better prevention, diagnosis, and clinical management. MicroRNA (miRNA) is a set of small, single-stranded, noncoding RNAs that target the 3'-untranslated region of an estimated 30% of all human genes to inhibit their expression. Our understanding of miRNA-mediated regulation of cancers has grown immensely over the past decade. Here we review currently available data on melanoma-associated miRNAs, highlighting those deregulated miRNAs targeting important genes and signaling pathways involved in the progression of melanocytes to primary and metastatic melanoma. Understanding the important roles of miRNAs in melanoma progression and metastasis development will contribute to the development of miRNA-targeted therapy in the future.
authors: Paul M
authors: PM
authors: Howell
authors: Xiaobo
authors: X
authors: Li
authors: Adam I
authors: AI
authors: Riker
authors: Yaguang
authors: Y
authors: Xi
references: Annu Rev Genet. 2004;38:365-411
references: 15568981
references: Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
references: 14973191
references: Genes Dev. 2002 Nov 1;16(21):2733-42
references: 12414724
references: Curr Biol. 2001 Feb 20;11(4):263-7
references: 11250155
references: J Mol Diagn. 2009 Sep;11(5):420-9
references: 19710399
references: Cell. 2004 Jan 23;116(2):281-97
references: 14744438
references: J Am Acad Dermatol. 2008 May;58(5 Suppl 2):S129-32
references: 18410798
references: Semin Cancer Biol. 2008 Apr;18(2):111-22
references: 18296065
references: Carcinogenesis. 2010 Apr;31(4):559-66
references: 20053927
references: Trends Cell Biol. 2008 Oct;18(10):505-16
references: 18774294
references: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65
references: 19029026
references: Int J Oncol. 2009 Aug;35(2):393-400
references: 19578755
references: Cancer Res. 2007 Jun 15;67(12):5699-707
references: 17575136
references: Nat Genet. 2005 Oct;37(10):1047-54
references: 16142232
references: Hematol Oncol Clin North Am. 2009 Jun;23(3):529-45, ix
references: 19464601
references: Nature. 2004 May 27;429(6990):457-63
references: 15164071
references: Genome Res. 2009 Jan;19(1):92-105
references: 18955434
references: Cancer Res. 2009 Jul 1;69(13):5312-20
references: 19549918
references: Cancer Res. 2001 Mar 1;61(5):2105-11
references: 11280773
references: Clin Cancer Res. 2009 May 1;15(9):2988-94
references: 19336521
references: Oncogene. 2008 Jun 19;27(27):3789-96
references: 18246121
references: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41
references: 16754881
references: Genes Dev. 2008 Nov 15;22(22):3172-83
references: 19056895
references: Oncol Rep. 2009 Sep;22(3):563-7
references: 19639204
references: Expert Opin Biol Ther. 2009 Jun;9(6):703-711
references: 19426115
references: J Mol Diagn. 2008 Nov;10(6):513-9
references: 18832457
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Cancer Sci. 2005 Feb;96(2):111-5
references: 15723655
references: Nat Struct Mol Biol. 2008 Apr;15(4):354-63
references: 18376413
references: Nature. 2005 Jun 9;435(7043):828-33
references: 15944707
references: Hematol Oncol Clin North Am. 2009 Jun;23(3):447-65, viii
references: 19464596
references: Cell Res. 2008 May;18(5):549-57
references: 18379589
references: Dermatol Clin. 2002 Oct;20(4):601-6
references: 12380047
references: Cancer Control. 2009 Jul;16(3):200-18
references: 19556960
references: Cell Cycle. 2009 Sep 1;8(17):2756-68
references: 19652553
references: J Clin Oncol. 2006 Sep 10;24(26):4340-6
references: 16908931
references: J Clin Invest. 2008 Nov;118(11):3660-70
references: 18924608
references: J Biol Chem. 2005 Apr 29;280(17):16635-41
references: 15722555
references: Nat Genet. 2005 Jul;37(7):766-70
references: 15965474
references: Biochem Biophys Res Commun. 2009 Feb 13;379(3):790-4
references: 19126397
references: Cancer Res. 2004 Jun 1;64(11):3753-6
references: 15172979
references: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17390-5
references: 17088530
references: J Transl Med. 2009 Oct 14;7:86
references: 19828018
references: Cancer Causes Control. 1999 Oct;10(5):407-16
references: 10530611
references: J Invest Dermatol. 2006 May;126(5):1102-10
references: 16410786
references: Science. 2001 Oct 26;294(5543):858-62
references: 11679671
references: Dev Dyn. 2008 Oct;237(10):2657-66
references: 18629870
references: Nat Rev Genet. 2002 Jun;3(6):453-61
references: 12042772
references: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9
references: 19188590
references: RNA. 2007 Oct;13(10):1668-74
references: 17698639
references: Int J Clin Exp Pathol. 2009 Mar 20;2(6):519-27
references: 19636399
references: J Invest Dermatol. 2009 Jul;129(7):1740-51
references: 19212343
references: Cancer Res. 2007 Mar 15;67(6):2456-68
references: 17363563
references: Cell. 2005 Jan 14;120(1):15-20
references: 15652477
references: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
references: 12434020
references: Cancer Res. 2008 Mar 1;68(5):1362-8
references: 18316599
references: Nature. 2004 Sep 16;431(7006):350-5
references: 15372042
references: J Invest Dermatol. 2010 Jan;130(1):28-37
references: 19571822
references: Pigment Cell Res. 2005 Jun;18(3):150-9
references: 15892711
references: Cancer Res. 2008 Dec 15;68(24):10128-36
references: 19074879
references: Oncogene. 2009 Oct 15;28(41):3663-70
references: 19648967
references: Cancer Res. 2004 Aug 1;64(15):5270-82
references: 15289333
references: Cancer Res. 2008 Jul 15;68(14):5743-52
references: 18632627
references: Cell. 2009 Jun 12;137(6):1005-17
references: 19524505
references: Nature. 2005 Jul 7;436(7047):117-22
references: 16001072
references: Photochem Photobiol. 2008 Mar-Apr;84(2):289-306
references: 18086245
references: Melanoma Res. 2008 Jun;18(3):184-90
references: 18477892
references: Int J Cancer. 2010 Jun 1;126(11):2553-62
references: 19830692
references: J Invest Dermatol. 2009 May;129(5):1219-24
references: 19005486
references: Nature. 2007 Jun 28;447(7148):1130-4
references: 17554337
references: Oncogene. 2008 Nov 6;27(52):6698-706
references: 18679415
references: Mol Vis. 2009 Oct 22;15:2146-54
references: 19898689
references: Cancer Cell. 2009 Dec 8;16(6):498-509
references: 19962668
references: Expert Rev Anticancer Ther. 2008 Nov;8(11):1759-65
references: 18983236
references: Oncogene. 1996 Dec 5;13(11):2339-47
references: 8957075
references: Cell Cycle. 2008 Aug 15;7(16):2591-600
references: 18719384